What are the risks of investing in JBIO?
J
What are the risks of investing in JBIO?
🦉
Jade Biosciences, Inc. (JBIO)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEOTom Frohlich
Jade Biosciences, Inc. is a biotechnology company focused on developing best-in-class therapies to address critical unmet needs in autoimmune diseases. Their lead asset, JADE-001, targets the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for the treatment of immunoglobulin A (IgA)...
Key Executives
| Name | Title |
|---|---|
| Amy Sullivan | Senior Vice President of Development Operations |
| Andrew James King | President of Research & Development |
| Bradford D. Dahms | CFO & Treasurer |
| Edward R. Conner | Chief Medical Officer |
| Elizabeth Balta | Chief Legal Officer & Corporate Secretary |
| Jason Wright | Senior Vice President of Chemistry, Manufacturing & Controls |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A